非洲一项临床试验被拒绝获取关键新冠药物帕罗韦德。 - Suppr

Suppr

超能文献

African clinical trial denied access to key COVID drug Paxlovid.

作者信息

Ledford Heidi, Maxmen Amy

出版信息

Nature. 2022 Apr;604(7906):412-413. doi: 10.1038/d41586-022-00919-5.

DOI:10.1038/d41586-022-00919-5

PMID:35379975

Abstract

摘要

相似文献

African clinical trial denied access to key COVID drug Paxlovid.

Nature. 2022 Apr;604(7906):412-413. doi: 10.1038/d41586-022-00919-5.

Three more points about Paxlovid for covid-19.

BMJ. 2022 Jun 7;377:o1397. doi: 10.1136/bmj.o1397.

Special Considerations for Paxlovid Treatment Among Transplant Recipients With SARS-CoV-2 Infection.

Am J Kidney Dis. 2022 Apr;79(4):480-482. doi: 10.1053/j.ajkd.2022.01.001. Epub 2022 Jan 12.

Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment - California, December 2021-May 2022.

MMWR Morb Mortal Wkly Rep. 2022 Jun 24;71(25):830-833. doi: 10.15585/mmwr.mm7125e2.

Public Health Impact of Paxlovid as Treatment for COVID-19, United States.

Emerg Infect Dis. 2024 Feb;30(2):262-269. doi: 10.3201/eid3002.230835. Epub 2024 Jan 5.

Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection.

Lancet Infect Dis. 2022 Sep;22(9):1279. doi: 10.1016/S1473-3099(22)00430-3. Epub 2022 Jul 14.

Experience Using Paxlovid for Patients With Coronavirus Disease 2019 in a Resource-Limited Emergency Department.

Ann Emerg Med. 2022 Oct;80(4):382-383. doi: 10.1016/j.annemergmed.2022.05.029.

Interactions listed in the Paxlovid fact sheet, classified according to risks, pharmacological groups, and consequences.

Rev Esp Quimioter. 2022 Aug;35(4):357-361. doi: 10.37201/req/054.2022. Epub 2022 Jul 13.

New Data on Paxlovid Reported.

Am J Nurs. 2022 Oct 1;122(10):59. doi: 10.1097/01.NAJ.0000890244.62778.a4.

In the age of Omicron variant: Paxlovid raises new hopes of COVID-19 recovery.

J Med Virol. 2022 May;94(5):1766-1767. doi: 10.1002/jmv.27540. Epub 2021 Dec 29.

引用本文的文献

Advances in the effectiveness and safety of azvudine treatment: a comprehensive review.

Front Pharmacol. 2025 Apr 25;16:1524072. doi: 10.3389/fphar.2025.1524072. eCollection 2025.

Data mining of adverse drug event signals with Nirmatrelvir/Ritonavir from FAERS.

PLoS One. 2024 Dec 31;19(12):e0316573. doi: 10.1371/journal.pone.0316573. eCollection 2024.

Funding and COVID-19 research in Africa: two years on, are the research needs of Africa being met?

Open Res Afr. 2023 Sep 12;6:16. doi: 10.12688/openresafrica.14185.1. eCollection 2023.

Efficacy and safety of azvudine in patients with COVID-19: A systematic review and meta-analysis.

Heliyon. 2023 Sep 14;9(9):e20153. doi: 10.1016/j.heliyon.2023.e20153. eCollection 2023 Sep.

A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants.

Emerg Microbes Infect. 2023 Dec;12(2):2246594. doi: 10.1080/22221751.2023.2246594.

Efficacy and Safety of Molnupiravir Treatment for COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Int J Antimicrob Agents. 2023 Aug;62(2):106870. doi: 10.1016/j.ijantimicag.2023.106870. Epub 2023 May 26.

Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?

Mol Ther Nucleic Acids. 2023 Jun 13;32:263-266. doi: 10.1016/j.omtn.2023.03.013. Epub 2023 Apr 6.

mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia.

Vaccine. 2023 Apr 6;41(15):2439-2446. doi: 10.1016/j.vaccine.2023.01.075. Epub 2023 Feb 3.

Voluntariness or legal obligation? An ethical analysis of two instruments for fairer global access to COVID-19 vaccines.

Front Public Health. 2023 Jan 26;11:995683. doi: 10.3389/fpubh.2023.995683. eCollection 2023.

Nasal irrigation efficiently attenuates SARS-CoV-2 Omicron infection, transmission and lung injury in the Syrian hamster model.

iScience. 2022 Dec 22;25(12):105475. doi: 10.1016/j.isci.2022.105475. Epub 2022 Nov 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验